n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Marshall, E; Zhuang, L | 1 |
| Baguley, BC; Finlay, GJ; Marshall, E; Matthews, JH; Paull, KD | 1 |
| Aboagye, EO; Baguley, BC; Brady, F; Brown, GD; Denny, WA; Gamage, SA; Luthra, SK; Myers, R; Osman, S; Price, PM; Rowlinson-Busza, G | 1 |
3 other study(ies) available for n-(2'-(dimethylamino)ethyl)acridine-4-carboxamide and Malignant Melanoma
| Article | Year |
|---|---|
Experimental solid tumour activity of N-[2-(dimethylamino)ethyl]-acridine-4-carboxamide.
Topics: Acridines; Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Cell Line; Colonic Neoplasms; Humans; Intercalating Agents; Lung Neoplasms; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Regression Analysis; Time Factors; Transplantation, Heterologous | 1995 |
In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance.
Topics: Acridines; Aminoacridines; Antineoplastic Agents; DNA Topoisomerases, Type I; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Intercalating Agents; Leukemia; Melanoma; Tumor Cells, Cultured | 1993 |
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
Topics: Acridines; Animals; Antineoplastic Agents; Carbon Radioisotopes; Female; Glioma; HT29 Cells; Humans; Inhibitory Concentration 50; Intercalating Agents; Isotope Labeling; Melanoma; Mice; Mice, Inbred ICR; Mice, Nude; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |